How big is the Korea Pharmaceutical Market?

The Korea Pharmaceutical Market size is expected to reach USD 22.65 billion in 2024 and grow at a CAGR of 2.40% to reach USD 25.5 billion by 2029. Read More

What is the current Korea Pharmaceutical Market size?

In 2024, the Korea Pharmaceutical Market size is expected to reach USD 22.65 billion. Read More

Who are the key players in Korea Pharmaceutical Market?

AbbVie Inc., AstraZeneca plc, Bayer AG, SAMSUNG PHARM. Co., LTD. and GlaxoSmithKline plc are the major companies operating in the Korea Pharmaceutical Market. Read More

What years does this Korea Pharmaceutical Market cover, and what was the market size in 2023?

In 2023, the Korea Pharmaceutical Market size was estimated at USD 22.11 billion. The report covers the Korea Pharmaceutical Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Korea Pharmaceutical Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the top growth opportunities in the Korean Pharma Market?

The top growth opportunities in the Korean Pharma Market are a) Biosimilars b) Contract manufacturing Read More

What are the top growth opportunities in the Korean Pharma Market?

The top growth opportunities in the Korean Pharma Market are a) Biosimilars b) Contract manufacturing Read More

Korea Pharmaceutical Industry Analysis | Market Growth, Size & Forecast Report

Korea Pharmaceutical Industry Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Korea Pharmaceutical Market Value & Analysis. The Market is Segmented by Therapeutic Category (Anti-Infectives, Cardiovascular, Gastrointestinal, Anti Diabetic, Respiratory, and Other Therapeutic Categories) and Drug Type (Prescription Drugs (Branded Drugs and Generic Drugs) and Over-The-Counter Drugs). The Value is Provided (in USD Million) for the Above Segments.

Korea Pharmaceutical Industry Overview

The Korean pharmaceutical market is highly competitive and consists of several major players. A few major players dominate the market in terms of market share. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. The key companies dominating the market are AbbVie Inc., AstraZeneca PLC, Bayer AG, and SAMSUNG PHARM. Co. LTD, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Eli Lilly and Company, Merck & Co. Inc., and Sanofi SA.